title: Current strategies for the treatment of hepatocellular carcinoma.
abstract: Although hepatic resection for hepatocellular carcinoma is the only known modality that offers an opportunity for cure, the practicing oncologist must be aware of alternative modes of therapy. A multidisciplinary approach between surgeon, medical oncologist, and invasive radiologist is necessary in exploring all potential therapeutic options. The oncologist must not only consider the stage of the tumor, but must also take into account the functional reserve of the nontumor-bearing liver in selecting appropriate therapy. More recently, hepatic transplantation has been recognized as a potential curative modality for specific tumor types and stages. Percutaneous ethanol injection and chemoembolization are excellent palliative measures. However, it remains clear that new and innovative techniques are necessary in the therapeutic, adjuvant, and palliative settings in the comprehensive care of the patient with hepatocellular carcinoma.
authors.affiliation: MD Anderson Cancer Center, Houston, Texas.
authors.forename: L M
authors.initials: LM
authors.lastname: Ellis
authors.forename: M L
authors.initials: ML
authors.lastname: Demers
authors.forename: M S
authors.initials: MS
authors.lastname: Roh
mesh_terms: D000782:Aneuploidy; D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000097:blood; D006528:Carcinoma, Hepatocellular / Q000401:mortality / Q000628:therapy*; D004621:Embolization, Therapeutic; D000431:Ethanol / Q000627:therapeutic use; D006498:Hepatectomy / Q000379:methods; D006801:Humans; D007267:Injections; D008113:Liver Neoplasms / Q000401:mortality / Q000628:therapy*; D016031:Liver Transplantation; D010166:Palliative Care; D011379:Prognosis; D011868:Radioisotopes / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D011868:Radioisotopes; D000431:Ethanol